Product Images Lucentis
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 25 images provide visual information about the product associated with Lucentis NDC 50242-082 by Genentech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - lucentis 01
Figure - lucentis 02
Figure - lucentis 03
Figure - lucentis 04
Figure 1 - lucentis 05
The text describes a syringe cap with a rubber stopper and finger grip, along with a Luerlock 0.05 mL dose mark plunger rod. The accompanying figure shows what the items look like.*
Figure 2 - lucentis 06
Figure 3 - lucentis 07
Figure 4 - lucentis 08
Figure 5 - lucentis 09
Figure - lucentis 10
Figure - lucentis 11
Figure - lucentis 12
Figure - lucentis 13
Figure - lucentis 14
This text refers to a small syringe with a volume capacity of 0.05 milliliters.*
Figure 1 - lucentis 15
Mean Change in Visual Activity for a condition or study named AMD-1 is being measured in meters or getters.*
Figure 2 - lucentis 16
Figure 3 - lucentis 17
Figure 4 - lucentis 18
Figure 5 - lucentis 19
Figure 6 - lucentis 20
Figure 7 - lucentis 21
Figure 8 - lucentis 22
Figure 9 - lucentis 23
PRINCIPAL DISPLAY PANEL - 0.5 mg Syringe Label - lucentis 24
This is a description of a drug product called Lucentis. It is a sterile, single-use syringe used for intravitreal injection only. The drug is indicated for the treatment of wet age-related macular degeneration (WAMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV). The syringe contains 0.5mg of ranibizumab. It is important to keep the product refrigerated and protected from light. It is manufactured by Genentech and is identified by the NDC code 50242.080-03.*
PRINCIPAL DISPLAY PANEL - 0.3 mg Syringe Packet - lucentis 25
This is a description of a medication called Lucentis (ranibizumab injection) that comes in a pre-filled syringe with a 0.3 mg dose. It is used for intravitreal injection only and is indicated for treating diabetic macular edema (DME) and diabetic retinopathy (DR). The medication is sterile, for single use only and should be kept refrigerated, protected from light, and not frozen. The text also includes the National Drug Code (NDC) number and an identification number (10198958).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.